glp-1 weight loss long-term REPEATED USE MAY PROMOTE LONG TERM GAIN: A new mice study found exactly that. Repeated cycles of GLP-1's may have long term adverse effects on the very thing they were GLP-1 Agonists For Obesity In

Regarding weight management , NICE Technology Appraisals provide specific guidance: TA875 recommends semaglutide 2.4 mg (Wegovy) as an option for managing overweight and obesity alongside a reduced-calorie diet and increased physical activity

The SURMOUNT-5 trial demonstrated that Zepbounds dual-agonist approach produces approximately 6% more weight loss compared to Wegovys GLP-1-only mechanism

3 Because postprandial hyperglycemia affects A1C to a greater degree than fasting hyperglycemia, the closer a patient is to the A1C goal, GLP-1 receptor agonists provide a viable treatment option to target postprandial glucose excursions due to their glucose-dependent effects on insulin secretion

It is not recommended for individuals under the age of 18 or over the age of 75